Literature DB >> 3851698

Modulation of natural killer activity by thymosin alpha 1 and interferon.

C Favalli, T Jezzi, A Mastino, C Rinaldi-Garaci, C Riccardi, E Garaci.   

Abstract

A single injection of alpha beta-interferon (alpha beta-IFN) (30000 units/mouse), a major biological modifier of natural killer (NK) cytolytic activity, strongly stimulated NK activity in normal mice, as expected, while the same treatment did not statistically alter the NK response in cyclophosphamide (CY)-suppressed animals. We investigated the possibility of thymosin alpha 1 cooperating with alpha beta-IFN in boosting NK activity in CY-suppressed animals. The results show that treatment with thymosin alpha 1 (200 micrograms/kg) for 4 days, followed by a single injection of alpha beta-IFN 24 h before testing, strongly restored NK activity in CY-suppressed mice. Thymosin alpha 1 was, moreover, able to accelerate the recovery rate of NK activity in bone marrow reconstituted murine chimeras. Taken together the data support the concept that the synergic effect between thymosin alpha 1 and alpha beta-IFN could be the result of effects on differentiation of the NK lineage at different levels.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3851698     DOI: 10.1007/bf00205574

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus.

Authors:  T L Low; G B Thurman; M McAdoo; J McClure; J L Rossio; P H Naylor; A L Goldstein
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

2.  The role of the thymus in the maintenance of natural killer cells in vivo.

Authors:  J P Flexman; P G Holt; G Mayrhofer; B I Latham; G R Shellam
Journal:  Cell Immunol       Date:  1985-02       Impact factor: 4.868

3.  Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.

Authors:  A L Goldstein; T L Low; M McAdoo; J McClure; G B Thurman; J Rossio; C Y Lai; D Chang; S S Wang; C Harvey; A H Ramel; J Meienhofer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  Interferons and the immune system.

Authors:  B R Bloom
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

5.  Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes.

Authors:  R B Herberman; J R Ortaldo; A Mantovani; D S Hobbs; H F Kung; S Pestka
Journal:  Cell Immunol       Date:  1982-02       Impact factor: 4.868

6.  Immunomodulating activity of thymosin fraction 5 and thymosin alpha 1 in immunosuppressed mice.

Authors:  Y Ohta; K Sueki; Y Yoneyama; E Tezuka; Y Yagi
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon.

Authors:  S Einhorn; H Blomgren; H Strander
Journal:  Int J Cancer       Date:  1980-10-15       Impact factor: 7.396

8.  Modulation of mouse natural killer cell activity by the serum thymic factor.

Authors:  P Bardos; J F Bach
Journal:  Scand J Immunol       Date:  1982-10       Impact factor: 3.487

9.  Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes.

Authors:  T Saito; R D Welker; H Fukui; R B Herberman; M A Chirigos
Journal:  Cell Immunol       Date:  1985-02       Impact factor: 4.868

10.  Induction and kinetics of natural killer cells in humans following interferon therapy.

Authors:  J R Huddlestone; T C Merigan; M B Oldstone
Journal:  Nature       Date:  1979-11-22       Impact factor: 49.962

View more
  3 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.

Authors:  A M Liberati; S Cinieri; M Fizzotti; M Schippa; S Ascani; V De Angelis; M Senatore; L Palmisano
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.

Authors:  E Garaci; A Mastino; F Pica; C Favalli
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.